chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had other side effects including hair loss all with the moderna; had a rash the second day, it started to go away but just woke up and it's spreading/Kinda sore and irritating/It's only on elbow; no rash with first phizer shot and second shot (moderna); This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (had other side effects including hair loss all with the moderna), RASH (had a rash the second day, it started to go away but just woke up and it's spreading/Kinda sore and irritating/It's only on elbow) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (no rash with first phizer shot and second shot (moderna)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Dose 1). Past adverse reactions to the above products included No adverse reaction with Pfizer.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (had other side effects including hair loss all with the moderna), RASH (had a rash the second day, it started to go away but just woke up and it's spreading/Kinda sore and irritating/It's only on elbow) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (no rash with first phizer shot and second shot (moderna)). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at an unspecified dose and frequency. At the time of the report, ALOPECIA (had other side effects including hair loss all with the moderna) and RASH (had a rash the second day, it started to go away but just woke up and it's spreading/Kinda sore and irritating/It's only on elbow) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (no rash with first phizer shot and second shot (moderna)) had resolved.            No concomitant drug information was provided.
10 days after receiving the MMR vaccine, my daughter lost her appetite, had a moderate fever (102 - 103), and experienced bouts of diarrhea. These symptoms lasted for roughly two days. The day after her fever broke, she began to develop what appeared to be a mild rash on her torso and neck (front/back). The rash progressed to her limbs and groin/buttocks and eventually began to itch. On day six of her symptoms, we took her to her pediatrician and she was diagnosed as having an MMR related reaction. They recommended Tylenol, Benadryl, and keeping her cool and hydrated.
Mild headache, worse than normal fatigue, stiff neck, muscle ache, hot flashes, flushed cheeks, itching. Rash to antecubital area of right arm starting on Sunday night.
10/17/2020 Stomach pain -- r side of navel burning, neck bilateral swollen lymph nodes,  inner side of knee area r leg pain and burning, sharp stabbing pain, and swelling. Loose stools 2 weeks after vaccine. All symptoms still persist.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 01/2023. I took over the counter medication to help with my symptoms. I previously tested positive for COVID-19 in 05/2022 and I took PAXLOVID. Since having COVID-19 twice, I feel congested every day. I feel like I can blow my nose all day.
day of shots t101 ax-next morning 6AM crying nonstop until 140PM;to hosp 9PM 15AUG96 wheezing not sucking;blood work, CXR;d/x papers per nurse stated rxn to shot;reported to PMD by mom;
Patient wanted ZOSTAVAX. Pt talked with technician about the flu shot the day before, when he came back, Tech. thought he wanted flu shot, the pharmacist gave pt flu shot. No adverse event.
pt recv vax 1OCT97 9-10AM;itching began in bed that noc;by morning entire body was affected w/hives, redness & itching;DPH relieved the sx;pt also described painful elbows & sore skin;
RIGHT ARM THE DAY AFTER INJECTION WAS LARGELY RED INFLAMMED AND PAINFUL TO TOUCH. ELBOW TO SHOULDER.
URI, nasal drainage, nausea, vomiting, abdominal pain, diarrhea.
Information has been received on 05-JAN-2018 regarding a case in litigation from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. The patient was inoculated with ZOSTAVAX (lot number and expiration unknown) subcutaneous on or about 11-JUN-2015, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 02-FEB-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster involving the cervical dermatome. The patient was prescribed VALTREX for management of her painful and persistent symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt experienced onset of Diaphoresis and pain to left and right temple exp. siezure lasting 30 secs/1 min by paramedic. S/P Ams/Hypotensive/Bradycardic/3+ Dis ph. Pt Denies siezure Hx. US New onset 1st. time siezure IV. placed NV meds given ALS transport Hosp
At 1158, RRT was initiated for a 23 y/o F with c/o of feeling to pass-out, had burry vision, and was diaphoretic. Vitals: BP ? 110/72, HR ? 96, RR ? 14. Vaccinated on the L arm at 1150. Has anxiety, NKA, and did not take any medications today. Head-to-toe assessment completed. During monitoring period, client?s condition improved. By the end of monitoring period, client was in stable condition. Client left vaccination clinic at 1210 in stable condition, ambulatory, breathing even and unlabored, accompanied by her boyfriend. Boyfriend drove client home. Client was not diaphoretic anymore and her vision was normal and clear.
Red blotch reaction; Itching; Injection site is warmer that the rest of her arm; Arm is red for about 4 inches by 2 inches at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red blotch reaction), PRURITUS (Itching), VACCINATION SITE WARMTH (Injection site is warmer that the rest of her arm) and VACCINATION SITE ERYTHEMA (Arm is red for about 4 inches by 2 inches at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATENOLOL and CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM WITH VITAMIN D 3) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced RASH MACULAR (Red blotch reaction), PRURITUS (Itching), VACCINATION SITE WARMTH (Injection site is warmer that the rest of her arm) and VACCINATION SITE ERYTHEMA (Arm is red for about 4 inches by 2 inches at the injection site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, RASH MACULAR (Red blotch reaction), PRURITUS (Itching), VACCINATION SITE WARMTH (Injection site is warmer that the rest of her arm) and VACCINATION SITE ERYTHEMA (Arm is red for about 4 inches by 2 inches at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Two months later I experienced fatigue. They gave me Amoxicillin and I broke out with hives. They had diagnosed as an Upper Respiratory Infection. I was unable to move. I could only eat watermelon and I lost 16 pounds. This month in Nov, I have experienced nasal issues, and I've never been sick in my life.
Fever of 102 about 36 hours with histamine like jacked up reaction could not sleep like I get with allergy attack. Then Covid Moderna Arm which spread for a week with hot to touch arm, painful itchy  and it spread to upper chest by clavicle and down a little past my elbow in a week.  I ran a low grade fever of about 99.2 for a week. Arm swelled.  Lymph nodes enlarged a little.  Nothing relieved it and I tried just about everything available over the counter and prescription steroid cream made it hurt more.  Arm slowly Improved BUT Second week heart was racing for two days pulse 90 and 100 when normal pulse is 76.
diarrhea; digestive pain; sluggish; felt like a hangover; normal throbbing pain in my arm; tingling down my arm to my fingers; throbbing pain in my arm; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL9269, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 04Feb2021 16:15 (at the age of 44-years-old) as single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient has no known allergies. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and cetirizine hydrochloride (ZYRTEC) (reported as allergy medicine), both taken for unspecified indication, start and stop dates were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. It was reported that 4 hours after the administration of the vaccine (04Feb2021 20:15), the patient experienced normal throbbing pain in my arm and tingling down my arm to my fingers. The next morning (05Feb2021), the patient was sluggish and felt like a hangover. From 24 hours after the administration of the vaccine (05Feb2021 16:15), the patient experienced digestive pain. The patient also experienced diarrhea on 05Feb2021 19:45. It was reported that the digestive pain started with normal bowel movements then it turned into diarrhea. The diarrhea was in different forms, from a little solid to water (this is not normal for the patient). The patient was not sure if it was the vaccine. But, the food intake was normal and the patient had not eaten any different. The patient wanted to share just in case others had experience the same thing. Therapeutic measures were taken as a result of the event diarrhea included over the counter anti-diarrhea medicine. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
On 11/15/05, patient started to develop welts or hives about 1 hours after getting her 4 month old vaccine. The welts increased in number and all over body. The rash disappeared following day spontaneously.
Ringing in ears, swollen glands in neck, joint pain, throbbing pain at injection site, swelling at injection site, stomachache, fever, chills causing uncontrollable shaking, exhaustion, shooting pains from elbow to hand of non-injection arm, runny nose
Painful swelling, itching on day 8 Red rash approximately 4x4 inches on day 10
damage to radial nerves, cannot use right hand, wrist drop, numb hand, fingers curled, pain. no signs of healing since 2/26/21
bit of fever; headache; chills; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  An 8-year-old female patient received bnt162b2 (BNT162B2), administration date 07Oct2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunization.   The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "bit of fever"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "headache"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "chills".  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
At 1249, 17-year old male client was administered Pfizer COVID-19 vaccine 2nd dose (Lot # EW0182, expiring 08/2021) in the right arm by registered nurse (RN) vaccinator. Client accompanied by mother. RN vaccinator requested emergency medical technician (EMT) assistance due to client report of feeling sweaty, tingling in both hands, and client nearly falling forward. EMT responded and brought gravity chair to vaccinator table and assisted client into gravity chair. Vital signs at 1257: blood pressure 95/60, heart rate 50, oxygen saturation 97%. RN lead assessed client. Client reported feeling tired and tingling in both hands. Client reported not eating breakfast. Client?s Mother reported that client closed eyes and put his head down immediately after vaccine administration, then opened his eyes after 3 seconds. Client?s mother reported client does not have allergies or chronic conditions and had sore arm after 1st dose of Pfizer. Client denied any other side-effects to first dose. Client?s mother reported client has aversion to needles. Client and client?s mother were provided vaccine education, were encouraged to follow-up with client?s primary care provider, and encouraged to report side-effects on website. Client was advised that he will be observed for at least 30 minutes. At 1300, client stood up from chair unassisted, walked to observation area unassisted with steady gait, and sat down in gravity chair. Client was provided one bottled water and two granola bar snacks. Vital signs at 1307: blood pressure 125/63, heart rate 62, oxygen saturation 96%. Client reported tingling was resolving. Vital signs at 1317: blood pressure 125/72, heart rate 57, oxygen saturation 97%. Client reported side-effects resolved and feeling better. Client reported driving to vaccine site and felt safe to drive. At 1325, client stood up from gravity chair unassisted and walked out of vaccine site unassisted with steady gait accompanied by mother.
Information has been received from a physician concerning that her daughter, who is a pharmaceutical representative, was vaccinated with GARDASIL in 2008. Subsequently the patient experienced arthritis in her wrist "a few months ago". It was noted that the patient used the computer a lot. The patient sought medical attention. At the time of the report, the patient recovered without treatment. The Health Care Professional contacted during telephone follow-up refused to give any information pertaining to the patient. No further information is available.
Urticaria, Hives; Red blotches in her arm, neck and legs; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 18:00 (at the age of 62-years-old) and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 31Mar2021 at 18:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic asthma and chronic obstructive pulmonary disease (COPD). The patient had allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included budesonide/ formoterol fumarate (SYMBICORT), fluticasone furoate (ARNUITY), tiotropium bromide monohydrate (SPIRIVA), montelukast sodium (SINGULAIR) and pseudoephedrine hydrochloride (SUDAFED 12); all from unknown date for an unknown indication and unknown if ongoing. On 15Mar2021, the patient experienced urticaria, hives and red blotches in her arm, neck and legs. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the reported events and included treatment with diphenhydramine hydrochloride (BENADRYL) tablets twice a day. The clinical outcome of the events urticaria, hives and red blotches in her arm, neck and legs was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Pericarditis Probable .Went to the ER Chest Pain. Pressure. feeling of pain around the heart Feels swollen. and bruised. Fast hard pounding heart skipped beats.. when strenuous movement pain across left chest.  Got the shot last Weds day Heart Trouble Thursday.  Never had heart trouble. Had 2 EKG's Both Normal. Chest X Ray normal blood work Normal. But Has Had pain since Thursday. and a squeezing feeling around the heart.  Doctor said inflammation of the Heart and Prescribed Aspirin 360 mg as is allergic to Advil. and Tylenol rest for 2 days
Lymphadenopathy left underarm; This is a spontaneous report from a contactable physician, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 22Apr2021 at 10:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW8727) via an unknown route of administration in the right arm on 01Apr2021 at 14:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced lymphadenopathy left underarm. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event and included treatment with ibuprofen (MANUFACTURER UNKNOWN) 400 mg. The clinical outcome of the event lymphadenopathy left underarm was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
DTAP, Prev given on 7/14/10. Onset erythema, tenderness on (R)-(L) F.A today. Also with fever and pharyngitis. Tx: cool compresses, TYLENOL PRN.
acute sense of smell; nose is swelling; This is a spontaneous report received from a contactable 84-year-old female nurse (patient). An 84-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 25Feb2021 (Lot Number: EN6206) as SINGLE DOSE for covid-19 immunisation. Medical history included ongoing asthma from 2019 and ongoing. Concomitant medications included albuterol [salbutamol] taken for wheezing from an unspecified start date and ongoing; beclometasone dipropionate (QVAR, lot number: ASR72A, expiration date: Sep2021) taken for shortness of breath from Aug2019 and ongoing; oxygen using this for sleep from 2012 and ongoing.  The patient experienced acute sense of smell and nose is swelling on 25Feb2021. Also on an unspecified date, the patient stated she has shrunk from 5 feet 5 1/4 inches to now 5 feet 2 inches. The events parosmia and nasal edema was assessed as medically significant by the reporter. Outcome of the event body height decreased was unknown while outcome of the remaining events was recovered on 25Feb2021.   Follow up attempts are needed. Further information is expected.; Sender's Comments: A possible contributory effect of suspect BNT162B2  on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Erythema, warmth, induration and tenderness spreading from DTaP injection site/-2 days after vaccine approaches 4-41/2 in by 3 in.
elevated temperature; extreme nausea; hot flashes; vomiting; chills; uncontrollable shivering; Fatigued; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6199) via unspecified route of administration in the left arm on 04Mar2021 at 16:00 (at the age of 46-years-old) as a single dose for Covid-19 immunisation and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6208) via unspecified route of administration in the left arm on 25Mar2021 at 10:30 (at the age of 46-years-old) as a single dose for Covid-19 immunisation.. The patient had medical history of pneumonia several years ago. Also, the patient was somewhat overweight. The patient had an illness with an 810-week long cough from late Feb2020 - mid Apr2020. It began with one day of chills and fever. Then went straight to respiratory symptoms. Fatigue and tightness in chest lingered for a year. The patient did not know if it was COVID-19, because tests were not available in patients area when the patient was sick, and once tests became available in patients area, the patient did not have qualifying symptoms. The patient never had an antibody test. The patients concomitant medication included occasional vitamin D (UNKNOWN MANUFACTURER), vitamin C (UNKNOWN MANUFACTURER), multivitamins (UNKNOWN MANUFACTURER) and probiotics (UNKNOWN MANUFACTURER). The patients reported allergies included full body rash and hives after MRI contrast dye. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021, about five or six hours after receiving first dose of vaccine, the patient began experiencing extreme nausea, hot flashes, vomiting, chills and uncontrollable shivering. It was cyclical, hitting the patient in the aforementioned order, over and over for 3-5 hours. Finally, these acute symptoms abated, and the patient fell asleep. When the patient woke the next day, the patients nausea was gone, and body temp was elevated by about one degree above the normal. The patient was fatigued and run down for the next 3-4 days. The patient received no treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of nausea was recovered on 05Mar2021. The clinical outcomes of hot flashes, vomiting, chills, shivering, fatigue and temperature elevation were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient said when she woke up the right side of her head and face was numb and tingly. She sat in a dark room all day and it slowly started getting better. She still has a little bit of tingles.
DR DIAGNOSED PATIENT WITH SHINGLES ON 7-30-2018 AND PRESCRIBED MEDROL DOSEPAK, ACYCLOVIR 400MG AND NYSTATIN CREAM.